In our clinical trials, people are using Neuralink devices to control computers and robotic arms with their thoughts. This technology will restore autonomy to those with unmet medical needs and unlock new dimensions of human potential.
Neuralink is developing a fully-implanted, wireless, high-channel count, brain-computer interface (BCI) with the goal of enabling people with paralysis to directly use their neural activity to operate computers and mobile devices with speed and ease.
Advanced, custom, low-power chips and electronics process neural signals, transmitting them wirelessly to the Neuralink Application, which decodes the data stream into actions and intents.
In January 2024, Noland became the first person to receive a Neuralink implant. The implant, or Link, is our fully implantable, cosmetically invisible, wireless brain-computer interface (BCI) designed to restore autonomy to people with paralysis.
An exploded view of the N1 Implant. Signals acquired by the electrodes are routed to electronics contained in the enclosure of the N1 Implant, which process and wirelessly transmit the neural data to an instance of the Neuralink Application running on an external device, such as a computer.
Welcoming our first pioneers: Five individuals with severe paralysis are now using Neuralink to control digital and physical devices with their thoughts, marking a profound step toward helping restore independence.
Last month, Alex,* the second participant in our PRIME Study,** received his Neuralink implant (Link). The surgery, conducted at the Barrow Neurological Institute, went well — Alex was discharged the following day, and his recovery has been smooth.
Neuralink’s First-in-Human Clinical Trial is Open for Recruitment We are happy to announce that we’ve received approval from the reviewing independent institutional review board and our first hospital site to begin recruitment for our first-in-human clinical trial.